CASI PHARMACEUTICALS INC (CASI) Forecast, Price Target & Analyst Ratings

NASDAQ:CASI • KYG1933S1012

Current stock price

0.2075 USD
-0.59 (-74.06%)
At close:
0.28 USD
+0.07 (+34.94%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CASI PHARMACEUTICALS INC (CASI).

Forecast Snapshot

Consensus Price Target

Price Target
$4.08
+ 1,866.27% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 30, 2026
Period
Q4 / 2025
EPS Estimate
-$0.37
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$4.08
Upside
+ 1,866.27%
From current price of $0.21 to mean target of $4.08, Based on 7 analyst forecasts
Low
$4.04
Median
$4.08
High
$4.20

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for CASI. The average price target is 4.08 USD. This implies a price increase of 1866.27% is expected in the next year compared to the current price of 0.2075.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CASI Current Analyst RatingCASI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

CASI Historical Analyst RatingsCASI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
CASI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CASI.
In the previous month the buy percentage consensus was at a similar level.
CASI was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-09-03HC Wainwright & Co.Reiterate Buy -> Buy
2025-05-19HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-09HC Wainwright & Co.Maintains Buy -> Buy
2024-05-15HC Wainwright & Co.Maintains Buy -> Buy
2023-11-15HC Wainwright & Co.Maintains Buy -> Buy
2023-08-14HC Wainwright & Co.Reiterate Buy -> Buy
2023-05-22HC Wainwright & Co.Reiterate Buy -> Buy
2022-11-16BTIGMaintains Buy
2022-11-15HC Wainwright & Co.Maintains Buy
2022-08-15HC Wainwright & Co.Maintains Buy
2022-06-03BTIGMaintains Buy
2022-05-16HC Wainwright & Co.Maintains Buy
2021-05-18BTIGInitiate Buy
2021-05-14HC Wainwright & Co.Maintains Buy
2021-04-26MizuhoInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 30, 2026
Period
Q4 / 2025
EPS Estimate
-$0.37
Revenue Estimate
Revenue Q2Q
-100.00%
EPS Q2Q
40.00%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

CASI is expected to report earnings on 3/30/2026. The consensus EPS estimate for the next earnings is -0.37 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
CASI revenue by date.CASI revenue by date.
43.107M
42.89%		33.879M
-21.41%		28.537M
-15.77%		13.76M
-51.78%
-100.00%		11.399M31.253M
174.17%		47.46M
51.86%		61.413M
29.40%
EBITDA
YoY % growth
CASI ebitda by date.CASI ebitda by date.
-24.069M
28.08%		-21.539M
10.51%		-32.081M
-48.94%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CASI ebit by date.CASI ebit by date.
-26.491M
24.92%		-25.28M
4.57%		-34.412M
-36.12%		-38.861M
-12.93%		-25.221M
35.10%		-27.04M
-7.22%		-29.242M
-8.14%		-21.262M
27.29%		-5.995M
71.81%		-3.891M
35.09%		5.128M
231.78%
Operating Margin
CASI operating margin by date.CASI operating margin by date.
-61.45%-74.62%-120.59%-282.42%N/AN/AN/A-186.52%-19.18%-8.20%8.35%
EPS
YoY % growth
CASI eps by date.CASI eps by date.
-3.40
-25.93%		-2.02
40.59%		N/A
-29.27%		-2.63
-0.78%		-1.44
45.35%		-1.42
1.42%		1.32
192.81%		1.59
20.93%		1.83
14.74%		N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.37
40.00%		-0.37
46.78%		-0.36
58.49%		-0.36
46.72%		-0.36
2.78%
Revenue
Q2Q % growth
-100.00%
-100.00%
-100.00%
-100.00%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-6.036M
20.09%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CASI Yearly Revenue VS EstimatesCASI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2019 2020 2021 2022 2023 2024 2025 2029 2030 2031 2032 20M 40M 60M
CASI Yearly EPS VS EstimatesCASI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -2 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
8.80%
EPS Next 5 Year
21.53%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
-14.87%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CASI PHARMACEUTICALS INC / CASI Forecast FAQ

What do analysts expect the price target to be for CASI PHARMACEUTICALS INC (CASI)?

7 analysts have analysed CASI and the average price target is 4.08 USD. This implies a price increase of 1866.27% is expected in the next year compared to the current price of 0.2075.

When does CASI PHARMACEUTICALS INC (CASI) report earnings?

CASI PHARMACEUTICALS INC (CASI) will report earnings on 2026-03-30, before the market open.

What are the consensus estimates for CASI PHARMACEUTICALS INC (CASI) next earnings?

The consensus EPS estimate for the next earnings of CASI PHARMACEUTICALS INC (CASI) is -0.37 USD and the consensus revenue estimate is 0 USD.

Can you provide the analyst count for CASI PHARMACEUTICALS INC stock?

The number of analysts covering CASI PHARMACEUTICALS INC (CASI) is 7.